Thesis (Ph. D.)--Ohio State University, 2006. / Available online via OhioLINK's ETD Center; full text release delayed at author's request until 2007 Jun 15

According to the cancer stem cells (CSCs) hypothesis, CSCs are responsible for the treatment failures. CSCs are a subset of cells possessing stemness properties within the heterogeneous tumor mass. Therapeutic intervention on Wnt signaling is of our great interest because an aberrant Wnt signaling is an important driver to maintain the potency of CSCs. In nasopharyngeal carcinoma (NPC), deregulated expression of the Wnt signaling components is frequently observed. ICG-001 is a selective Wnt modulator (CBP antagonist) that specifically interrupts the interaction between β-catenin and CBP, thereby encourages the interaction between β-catenin and p300 and the subsequent differentiation and reduction of the CSCs subset. For this reason, the present study aimed to evaluate the therapeutic potential of ICG-001 in NPC. Results showed that ICG-001 inhibited both the migration of the NPC cells and the formation of tumor spheres. In the first part of the mechanistic studies (Chapter 3), ICG-001 was found to restore the expression of miR-150 in NPC cells. MiR-150 was further found to directly reduce CD44 expression and inhibit NPC cell migration. In the second part of the mechanistic studies (Chapter 4), ICG-001 was found to reduce the expression of Evi1 in NPC cells. The effect was accompanied with the inhibition of both the NPC cells migration and the tumor spheres formation. Two molecular axes, namely miR-96/Evi1/miR-449a and survivin/Evi1/miR-449a, were found to be involved in the inhibition of the tumor cell migration and spheroids formation. The therapeutic potential of using this CBP antagonist (ICG-001) in NPC, namely the in vitro and in vivo efficacy of ICG-001 combined with cisplatin, was examined (Chapter 5). Concurrent treatment of ICG-001 and cisplatin exhibited a synergistic inhibition on the in vitro growth and the tumor sphere forming capacity of NPC cells as well as the growth of NPC xenografts. Taken together, results presented in this thesis suggested that ICG-001 (PRI-724 is the analog of ICG-001 currently used in clinical trials) has a therapeutic potential in NPC.

Orientadores: Lucia Elvira Alvares, Jose Xavier Neto / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-13T10:17:43Z (GMT). No. of bitstreams: 1 Sobreira_DeboraRodrigues_M.pdf: 2481929 bytes, checksum: 2cb1105ccc78322b5f11f4528108d2fc (MD5) Previous issue date: 2009 / Resumo: Splicing Alternativo é um mecanismo importante para expandir a diversidade protéica em eucariotos. Este processo permite a produção de diferentes mRNAs a partir de uma mesma molécula de pré-RNA e é freqüentemente utilizado pelos genes envolvidos no desenvolvimento embrionário. O gene Oapper1 (Opr1) é um importante modulador da via de sinalização Wnt, atuando em diversos processos como especificação do tecido neural, morfogênese cefálica e desenvolvimento do coração e olho. Entre seus parceiros estão as '1lOléculas Dishevelled, o fator de transcrição TCF-3 (ambas as moléculas envolvidas na sinalização Wnt) e Dbf-4 (regulador do ciclo celular). Considerando que Dpr1 possui uma estrutura modular e interage com diferentes parceiros moleculares através de diferentes domínios estruturais, esta molécula poderia utilizar a maquinaria de Splicing Alternativo para combinar diferentes domínios e conseqüentemente ampliar suas funções biológicas. Neste estudo, descrevemos uma nova Variante do gene Opr1, identificada inicialmente no transcriptoma de camundongo utilizando ferramentas de Bioinformática. Esta nova Variante é maior em 111 pb em relação à codificada pela seqüência referência de RNAm para Dpr1 RefSeq, as quais são denominadas, respectivamente, como Variante A e Variante B. Estes transcritos variantes são gerados por dois sítios aceptores de Splicing distintos presentes no início do exon 4. O segmento exclusivo da Variante A codifica 37 aminoácidos localizados na região onde Opr1 se associa ao fator transcricional TCF-3. Uma análise comparativa do lócus de Opr1 entre diversos vertebrados (peixe, anfíbio, galinha, camundongo e humano) revelou que ambos os sítios aceptores de Splicing são conservados nos tetrápodas, enquanto que em peixe apenas um sítio é encontrado. Ensaios de RT-PCR confirmaram nossos resultados obtidos em Bioinformática. Além disso, demonstramos que ambas as Variantes são co-expressas ao longo do desenvolvimento de galinha, sugerindo que a concentração relativa dessas moléculas pode ser importante para a sua função. Finalmente, análises de pressão seletiva foram realizadas para a molécula de Dpr1. Apesar de não se confirmar a presença de seleção positiva ao longo da proteína Dpr1, o exon 4 parece estar sob pressão seletiva mais relaxada quando comparado aos outros exons. Nossos resultados são consistentes com a hipótese de que o mecanismo de Splicing Alternativo atua acelerando a evolução, reduzindo a seleção negativa. / Abstract: Alternative splicing is an important mechanism to expand protein diversity in eukaryotes. This process allows the production of different mRNAs from a single coding sequence and is frequentfy used by genes involved in development. Oapper 1 (Opr1) is an important rnodulator of Wnt signalling, working in several developmental processes, such as neural tissue specification, head morphogenesis, heart and eye development. While its interaction with Oishevelled is known to modulate Wnt signalling both in vivo and in vitre, the interaction wrth other molecules is required to mediate its multiple biological functions. Considering that Dpr1 has a modular structure that mediates its interaction with different partners through different structural domains, this molecule could greatly benefit from alternative splicing in order to combine different domains and consequently amplify its biological functions. In the present study we describe a new Opr1 isoform that was initially identified in the mouse transcriptome using bioinformatic tools. This isoform is 111 pb longer than the one encoded by the RefSeq mRNA for Opr1, here named O and E isoforms, respectively. The variant transcripts are generated through two distinct acceptor splice sites in exon 4. The segment exclusive of the O isoform is in frame and encodes 37 residues located in a variable region of Oprl exon 4, known to be necessary for the interaction with the transcriptional factor Tcf3. comparative analysis of the Opr1 locus among fish, frog, chicken, mouse and human revealed that in tetrapods two acceptor splice sites are conserved in the beginning of the exon 4, while in fish a single acceptor splice site is found. RT-PCR using species-specific primers confirmed the expression of the O and E isoforms in tetrapods while in fish only the O isoform was detected. In addition, we showed that the Opr1 isoforms are coexpressed throughout chicken development, suggesting that the relative concentration of these molecules may be important for their functionality. Finally, even though no evidence of positive selection was detected for the entire Dpr1 protein, exon 4 seems to be under more relaxed selective pressure than the other exons. These results are consistent with the notion that alternative splicing can act as a mechanism for opening accelerated paths of evolution by reducing negative selection pressure. / Mestrado / Histologia / Mestre em Biologia Celular e Estrutural

Le muscle squelettique adulte a une importante capacité à se régénérer après une lésion. La régénération musculaire dépend de divers signaux moléculaires tels que l’activation de la signalisation Wnt dans les cellules souches musculaires, appelées cellules satellites. Les protéines R-spondins (Rspo) composent une famille de quatre protéines qui ont un rôle d’activateurs/potentialisateurs sur les voies Wnt dans les cellules souches de différents tissus. Bien qu’il soit connu que ces protéines sont importantes pour la régénération de ces tissus, leur rôle dans la myogenèse régénérative n’a pas été étudié à ce jour. L’expression génique de R-spondin1 étant sur-régulée par Pax7, le marqueur des cellules satellites, nous avons émis l’hypothèse que R-spondin1 participe à la régénération musculaire. Nous avons, tout d’abord, isolé les cellules souches musculaires des modèles murins d’invalidation constitutive pour Rspo1 et avons observé qu’une déficience de R-spondin1 n’altère pas le cycle cellulaire de ces cellules. Cependant, une altération de l’expression de Rspo1 induit un défaut global de la cinétique de différenciation myogénique. Nous montrons que R-spondin1 inhibe la fusion des cellules musculaires puisque les myotubes déficients pour R-spondin1 possèdent un plus grand nombre de noyaux. Nous avons ensuite induit la régénération du muscle squelettique Tibalis Antérieur par une injection de Cardiotoxine et nous avons analysé les muscles à différents temps de régénération. Nos données prouvent qu’en l’absence de R-spondin1, les cellules souches présentent un retard de différenciation alors qu’elles possèdent une plus grande capacité de fusion, ayant pour conséquence une hypertrophie des myofibres dans le muscle. Concordant au rôle de R-spondin dans les cellules souches intestinales ou dans le follicule pileux, la protéine R-spondin1 stimule l’expression des gènes cibles de la voie Wnt canonique dans les cellules souches musculaires. Nous avons mis en évidence que R-spondin1 potentialise la voie Wnt canonique et régule négativement l’activation de la voie non-canonique dans les cellules. Nos résultats démontrent que la protéine R-spondin1 contribue à la régénération du muscle squelettique adulte par la régulation de l’activation des voies Wnt. / Adult mammalian skeletal muscles have the remarkable ability to repair after injury. Muscle regeneration depends on various cellular and molecular responses, such as activation of Wnt signaling pathways in muscle stem cells called satellite cells. R-spondin (Rspo) proteins are able to potentiate Wnt signaling pathways in vivo in many stem cells and play important role for regeneration of several tissues. The role of R-spondin in injury-induced myogenesis has not been studied. Given that R-spondin1 gene expression is up-regulated by Pax7, the satellite cell-specific transcription factor, we explored the hypothesis that R-spondin1 plays a role during skeletal muscle regeneration. We firstly isolated primary myoblasts from Rspo1 constitutive knock-out mice and observed that a depletion of Rspo1 did not alter cell cycle of these cells. However, a lack of R-spondin1 on cells resulted in global alteration of differentiation kinetics. We found that R-spondin1 inhibits muscle cell fusion, as Rspo1 knock-out myotubes contain an higher number of myonuclei. Then, we injured the Tibialis Anterior (TA) muscle of Rspo1-null mice and littermates controls by Cardiotoxin injection and analyzed muscle regeneration at different time points following injury. Our data show that R-spondin1 removal results in a delay of stem cell differenciation. In contrast, a R-spondin1 deficiency leads to better cell capacity to fuse to dommaged myofibers, giving rise to myofiber hypertrophy. As with other tissue-specific stem cells, such as hair follicle or intestinal crypt stem cells, R-spondin1 potentiates canonical Wnt signaling target genes expression in muscle stem cells. We proved that R-spondin1 potentiates canonical Wnt signaling target genes expression and negatively regulates non-canonical signaling in muscle stem cells. Our results demonstrate that R-spondin1 is crucial for adult muscle regeneration through a tighly cross-talk regulation between Wnt signalings.